Wasserman Chad J 4
4 · HCA Healthcare, Inc. · Filed Feb 6, 2024
Insider Transaction Report
Form 4
Wasserman Chad J
SVP and CIO
Transactions
- Exercise/Conversion
Common Stock
2024-02-03+127→ 417.31 total - Sale
Common Stock
2024-02-02$312.04/sh−652$203,451→ 290.31 total - Exercise/Conversion
Restricted Stock Units
2024-02-03−127→ 128 totalExp: 2031-02-03→ Common Stock (127 underlying) - Tax Payment
Common Stock
2024-02-03$309.42/sh−38$11,758→ 379.31 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.0111 to $312.06, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Includes 35.3102 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
- [F3]Restricted stock units convert into common stock on a one-for-one basis.
- [F4]The restricted stock units vest in two equal annual installments beginning February 3, 2024.